Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8492)
All Articles published online
|
Apr 14, 2007 (publication date) through May 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: Gadget or magic? World J Gastroenterol 2007; 13(14): 2028-2036 [PMID: 17465443 DOI: 10.3748/wjg.v13.i14.2028] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i14/2028.htm |
| Number | Citing Articles |
| 1 |
Renato Tozzoli. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases. Clinical Chemistry and Laboratory Medicine 2008; 46(5) doi: 10.1515/CCLM.2008.138
|
| 2 |
Stepan Coufal, Natalie Galanova, Lukas Bajer, Zuzana Gajdarova, Dagmar Schierova, Zuzana Jiraskova Zakostelska, Klara Kostovcikova, Zuzana Jackova, Zuzana Stehlikova, Pavel Drastich, Helena Tlaskalova-Hogenova, Miloslav Kverka. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response. Cells 2019; 8(7): 719 doi: 10.3390/cells8070719
|
| 3 |
Sudha Anupindi, Rama Ayyala, Judith Kelsen, Petar Mamula, Kimberly E. Applegate. Evidence-Based Imaging in Pediatrics. 2010; : 487 doi: 10.1007/978-1-4419-0922-0_33
|
| 4 |
Peter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, Karoly Palatka, Zsuzsanna Vitalis, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Zsolt Barta, Winfried Stocker, Janos Papp, Gabor Veres, Maria Papp. Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort. Inflammatory Bowel Diseases 2009; 15(3): 365 doi: 10.1002/ibd.20778
|
| 5 |
Giulia Roda, Alessandra Caponi, Marco Benevento, Paolo Nanni, Laura Mezzanotte, Andrea Belluzzi, Lloyd Mayer, Aldo Roda. New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(7): 1239 doi: 10.1002/ibd.21212
|
| 6 |
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2016; 22(8): 2016 doi: 10.1097/MIB.0000000000000836
|
| 7 |
Levent Kilic, Umut Kalyoncu, Omer Karadag, Ali Akdogan, Ismail Dogan, Sule Apras Bilgen, Sedat Kiraz, Ihsan Ertenli. Inflammatory bowel diseases and Takayasu's arteritis: coincidence or association?. International Journal of Rheumatic Diseases 2016; 19(8): 814 doi: 10.1111/1756-185X.12837
|
| 8 |
Barry Hall, Grainne Holleran, Deirdre McNamara. Current applications and potential future role of wireless capsule technology in Crohn’s disease. Scandinavian Journal of Gastroenterology 2014; 49(11): 1275 doi: 10.3109/00365521.2014.962606
|
| 9 |
Valentina Zanin, Ludovica Segat, Anna Monica Bianco, Lara Padovan, Nathalia de Alencar Cunha Tavares, Sergio Crovella. DEFB1 gene 5′ untranslated region (UTR) polymorphisms in inflammatory bowel diseases. Clinics 2012; 67(4): 395 doi: 10.6061/clinics/2012(04)14
|
| 10 |
Eleftheria Pertsinidou, Benita Salomon, Daniel Bergemalm, Samira Salihovic, Charlotte R H Hedin, Maria Ling Lundström, Åsa V Keita, Maria K Magnusson, Carl Eriksson, May-Bente Bengtson, Olle Grännö, Tone B Aabrekk, Robert Movérare, Niclas Rydell, Helena Ekoff, Johan Rönnelid, Sven Almer, Hans Strid, Henrik Hjortswang, Francesca Bresso, Johann Hreinsson, André Blomberg, Adam Carstens, Mauro D’Amato, Trond E Detlie, Gert Huppertz-Hauss, Randi Opheim, Petr Ricanek, Vendel A Kristensen, Lena Öhman, Johan D Söderholm, Robert Kruse, Carl M Lindqvist, Marie Carlson, Dirk Repsilber, Marte L Høivik, Jonas Halfvarson. Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype. Journal of Crohn's and Colitis 2025; 19(5) doi: 10.1093/ecco-jcc/jjaf062
|
| 11 |
D. А. Kuznetsova, S. V. Lapin, O. B. Shchukina. The diagnostic and prognostic value of serological markers of inflammatory bowel diseases (a literature review). Almanac of Clinical Medicine 2020; 48(6): 364 doi: 10.18786/2072-0505-2020-48-061
|
| 12 |
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
|
| 13 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approach. European Journal of Internal Medicine 2018; 48: 35 doi: 10.1016/j.ejim.2017.10.006
|
| 14 |
Dan Vălean, Roxana Zaharie, Roman Țaulean, Lia Usatiuc, Florin Zaharie. Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review. International Journal of Molecular Sciences 2024; 25(4): 2077 doi: 10.3390/ijms25042077
|
| 15 |
Michitaka Kohashi, Shin Nishiumi, Makoto Ooi, Tomoo Yoshie, Atsuki Matsubara, Makoto Suzuki, Namiko Hoshi, Koji Kamikozuru, Yoko Yokoyama, Ken Fukunaga, Shiro Nakamura, Takeshi Azuma, Masaru Yoshida. A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis. Journal of Crohn's and Colitis 2014; 8(9): 1010 doi: 10.1016/j.crohns.2014.01.024
|
| 16 |
Filomena Pascarella, Massimo Martinelli, Erasmo Miele, Annamaria Staiano. Novità in tema di malattie infiammatorie croniche intestinali. Area Pediatrica 2012; 13(4): 85 doi: 10.1016/j.arped.2012.10.002
|
| 17 |
Michael Mahler, Dimitrios P. Bogdanos, Polychronis Pavlidis, Marvin J. Fritzler, Elena Csernok, Jan Damoiseaux, Chelsea Bentow, Zakera Shums, Alastair Forbes, Gary L. Norman. PR3-ANCA: A promising biomarker for ulcerative colitis with extensive disease. Clinica Chimica Acta 2013; 424: 267 doi: 10.1016/j.cca.2013.06.005
|
| 18 |
Vishwajeet Singh, Dheeraj Kumar Gupta, Rahul Janak Sinha, Seema Mehrotra. Ileovesical Fistulae: A Rare Complication of Crohn Disease. UroToday International Journal 2013; 6(02) doi: 10.3834/uij.1944-5784.2013.04.10
|
| 19 |
Francesca A. R. Silva, Bruno L. Rodrigues, Maria de Lourdes S. Ayrizono, Raquel F. Leal. The Immunological Basis of Inflammatory Bowel Disease. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2097274
|
| 20 |
Maria Papp, Nora Sipeki, Zsuzsanna Vitalis, Tamas Tornai, Istvan Altorjay, Istvan Tornai, Miklos Udvardy, Kai Fechner, Silvia Jacobsen, Bianca Teegen, Andrea Sumegi, Gabor Veres, Peter Laszlo Lakatos, Janos Kappelmayer, Peter Antal-Szalmas. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. Journal of Hepatology 2013; 59(3): 457 doi: 10.1016/j.jhep.2013.04.018
|
| 21 |
Asher Kornbluth, David B Sachar. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee. American Journal of Gastroenterology 2010; 105(3): 501 doi: 10.1038/ajg.2009.727
|
| 22 |
Amit Kaul, Susan Hutfless, Ling Liu, Theodore M. Bayless, Michael R. Marohn, Xuhang Li. Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis. Inflammatory Bowel Diseases 2012; 18(10): 1872 doi: 10.1002/ibd.22862
|
| 23 |
Andrea Michielan, Daniela Basso, Matteo Martinato, Surajit Pathak, Antara Banerjee, Lydia Oliva, Mario Plebani, Giacomo Carlo Sturniolo, Renata D’Incà. Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives. Digestive and Liver Disease 2013; 45(11): 894 doi: 10.1016/j.dld.2013.01.017
|
| 24 |
Sara Ashorn, Teemu Honkanen, Kaija-Leena Kolho, Merja Ashorn, Tuuli Välineva, Bo Wei, Jonathan Braun, Immo Rantala, Tiina Luukkaala, Sari Iltanen. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflammatory Bowel Diseases 2009; 15(2): 199 doi: 10.1002/ibd.20535
|
| 25 |
Ashwin N Ananthakrishnan. Personalizing therapy for inflammatory bowel diseases. Expert Review of Gastroenterology & Hepatology 2013; 7(6): 549 doi: 10.1586/17474124.2013.824693
|
| 26 |
Dalin Li, Mark S. Silverberg, Talin Haritunians, Marla C. Dubinsky, Carol Landers, Joanne M. Stempak, Raquel Milgrom, Xiuqing Guo, Yii-Der Ida Chen, Jerome I. Rotter, Kent D. Taylor, Dermot P. B. McGovern, Stephan R. Targan. TNFRSF1B Is Associated with ANCA in IBD. Inflammatory Bowel Diseases 2016; 22(6): 1346 doi: 10.1097/MIB.0000000000000771
|
| 27 |
Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. 2019; : 155 doi: 10.1007/978-981-13-6524-9_10
|
| 28 |
Armen Aboulian, Ravin R. Kumar. Colorectal Surgery. 2013; : 17 doi: 10.1016/B978-1-4377-1724-2.00002-7
|
| 29 |
Chiara De Cassan, Bénédicte De Vroey, Catherine Dussault, Eric Hachulla, Sebastien Buche, Jean-Frédéric Colombel. Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease. Journal of Crohn's and Colitis 2011; 5(4): 364 doi: 10.1016/j.crohns.2011.03.006
|
| 30 |
Mária Papp. Possible pathogenetic role of vascular, immunological and genetic factors in certain gastoenterological disorders. Orvosi Hetilap 2008; 149(48): 2269 doi: 10.1556/oh.2008.28463
|
| 31 |
Maria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, Michael Mahler, Miguel Angel Mieses, Beatriz Castro, Montserrat Rivero, Javier Crespo, Marcos López-Hoyos. Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease. Clinical Reviews in Allergy & Immunology 2013; 45(1): 109 doi: 10.1007/s12016-012-8349-4
|
| 32 |
Gerhard Rogler, Luc Biedermann. Clinical Utility of Biomarkers in IBD. Current Gastroenterology Reports 2015; 17(7) doi: 10.1007/s11894-015-0449-x
|
| 33 |
Peter Laszlo Lakatos, Maria Papp, Florian Rieder. Serologic Antiglycan Antibodies in Inflammatory Bowel Disease. American Journal of Gastroenterology 2011; 106(3): 406 doi: 10.1038/ajg.2010.505
|
| 34 |
Anet A Soubières, Andrew Poullis. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 41-50 doi: 10.4292/wjgpt.v7.i1.41
|
| 35 |
Polychronis Pavlidis, Lars Komorowski, Bianca Teegen, Christos Liaskos, Andreas L. Koutsoumpas, Daniel S. Smyk, Carlo Perricone, Maria G. Mytilinaiou, Winfried Stocker, Alastair Forbes, Dimitrios P. Bogdanos. Diagnostic and clinical significance of Crohn’s disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies. Clinical Chemistry and Laboratory Medicine (CCLM) 2016; 54(2) doi: 10.1515/cclm-2015-0376
|
| 36 |
Zara Manuelyan, Edward Butt, Sreeram Parupudi. Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management. Disease-a-Month 2024; 70(1): 101674 doi: 10.1016/j.disamonth.2023.101674
|
| 37 |
Elisabet Cantó, Carlos Zamora, Esther Garcia-Planella, Jordi Gordillo, M Angels Ortiz, Lidia Perea, Silvia Vidal. Bacteria-related Events and the Immunological Response of Onset and Relapse Adult Crohn’s Disease Patients. Journal of Crohn's and Colitis 2019; 13(1): 92 doi: 10.1093/ecco-jcc/jjy138
|
| 38 |
Davide Giuseppe Ribaldone, Selvaggia Brigo, Michela Mangia, Giorgio Maria Saracco, Marco Astegiano, Rinaldo Pellicano. Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines 2020; 7(6): 33 doi: 10.3390/medicines7060033
|
| 39 |
Xuhang Li, Laurie Conklin, Philip Alex. New serological biomarkers of inflammatory bowel disease. World Journal of Gastroenterology 2008; 14(33): 5115-5124 doi: 10.3748/wjg.14.5115
|
| 40 |
P. L. Lakatos, I. Altorjay, Y. Mándi, L. Lakatos, J. Tumpek, A. Kovacs, T. Molnar, Z. Tulassay, P. Miheller, K. Palatka, T. Szamosi, S. Fischer, J. Papp, M. Papp. Interaction between seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins?. Tissue Antigens 2008; 71(6): 552 doi: 10.1111/j.1399-0039.2008.01049.x
|
| 41 |
I. Ferrer Bradley, J. Hinojosa del Val. Definiciones, manifestaciones clínicas y diagnóstico de la enfermedad de Crohn. Medicine - Programa de Formación Médica Continuada Acreditado 2012; 11(5): 257 doi: 10.1016/S0304-5412(12)70297-4
|
| 42 |
Wasseem Skef, Matthew J Hamilton, Thurayya Arayssi. Gastrointestinal Behçet's disease: A review. World Journal of Gastroenterology 2015; 21(13): 3801-3812 doi: 10.3748/wjg.v21.i13.3801
|
| 43 |
Hubert de Boysson, Nicolas Martin Silva, Claire de Moreuil, Antoine Néel, Mathilde de Menthon, Olivier Meyer, David Launay, Christian Pagnoux, Loïc Guillevin, Xavier Puéchal, Boris Bienvenu, Achille Aouba. Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Medicine 2016; 95(11): e2957 doi: 10.1097/MD.0000000000002957
|
| 44 |
Sudha A. Anupindi, Rama Ayyala, Judith Kelsen, Petar Mamula, Kimberly E. Applegate. Evidence-Based Imaging. 2011; : 571 doi: 10.1007/978-1-4419-7777-9_35
|
| 45 |
P. L. Lakatos. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 43 doi: 10.1007/978-1-4020-8767-7_6
|
| 46 |
Heba N. Iskandar, Matthew A. Ciorba. Biomarkers in inflammatory bowel disease: current practices and recent advances. Translational Research 2012; 159(4): 313 doi: 10.1016/j.trsl.2012.01.001
|
| 47 |
Na‐Young Han, Eun Hee Kim, Joon Choi, Hookeun Lee, Ki‐Baik Hahm. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease. Journal of Digestive Diseases 2012; 13(10): 497 doi: 10.1111/j.1751-2980.2012.00625.x
|
| 48 |
Omar I. Saadah, Jamil A. Al-Mughales. Pediatric Inflammatory Bowel Disease with Cytoplasmic Staining of Antineutrophil Cytoplasmic Antibodies. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/196012
|
| 49 |
Jong-Min Park, Na Young Han, Young-Min Han, Mi Kyung Chung, Hoo Keun Lee, Kwang Hyun Ko, Eun-Hee Kim, Ki Baik Hahm. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?. World Journal of Gastroenterology 2014; 20(37): 13466-13476 doi: 10.3748/wjg.v20.i37.13466
|
| 50 |
Maria Papp, Istvan Altorjay, Gabriella Lakos, Judit Tumpek, Sandor Sipka, Tamas Dinya, Karoly Palatka, Gabor Veres, Miklos Udvardy, Peter Laszlo Lakatos. Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease. Clinical and Vaccine Immunology 2009; 16(4): 464 doi: 10.1128/CVI.00002-09
|
| 51 |
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
|
| 52 |
Maria Papp, Istvan Altorjay, Nir Dotan, Karoly Palatka, Ildiko Foldi, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gary L. Norman, Tamas Szamosi, Janos Papp, Peter L. Lakatos. New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort. The American Journal of Gastroenterology 2008; 103(3): 665 doi: 10.1111/j.1572-0241.2007.01652.x
|
| 53 |
D. Mutter, L.O. Perotto. Facharztwissen Viszeral- und Allgemeinchirurgie. 2017; : 25 doi: 10.1007/978-3-662-48308-4_2
|
| 54 |
Paolo Nanni, Laura Mezzanotte, Giulia Roda, Alessandra Caponi, Fredrik Levander, Peter James, Aldo Roda. Differential proteomic analysis of HT29 Cl.16E and intestinal epithelial cells by LC ESI/QTOF mass spectrometry. Journal of Proteomics 2009; 72(5): 865 doi: 10.1016/j.jprot.2008.12.010
|
| 55 |
Johannes Schulte-Pelkum, Antonella Radice, Gary L. Norman, Marcos Lόpez Hoyos, Gabriella Lakos, Carol Buchner, Lucile Musset, Makoto Miyara, Laura Stinton, Michael Mahler. Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies. Journal of Immunology Research 2014; 2014: 1 doi: 10.1155/2014/185416
|
| 56 |
Maria Papp, Peter Laszlo Lakatos, Jolan Harsfalvi, Gyula Farkas, Karoly Palatka, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Ferenc Nagy, Gabor Veres, Laszlo Lakatos, Agota Kovacs, Tamas Dinya, Agnes Katalin Kocsis, Janos Papp, Istvan Altorjay. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort. Human Immunology 2010; 71(4): 407 doi: 10.1016/j.humimm.2010.01.012
|
| 57 |
Na‐Young Han, Wooseok Choi, Jong‐Moon Park, Eun Hee Kim, Hookeun Lee, Ki‐Baik Hahm. Label‐free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease. Journal of Digestive Diseases 2013; 14(4): 166 doi: 10.1111/1751-2980.12035
|
| 58 |
Elisabetta Dal Pont, Renata D’Incà, Antonino Caruso, Giacomo Carlo Sturniolo. Non-invasive investigation in patients with inflammatory joint disease. World Journal of Gastroenterology 2009; 15(20): 2463-2468 doi: 10.3748/wjg.15.2463
|
| 59 |
Levent Filik, Ibrahim Biyikoglu. Differentiation of Behcet’s disease from inflammatory bowel diseases: Anti-saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World Journal of Gastroenterology 2008; 14(47): 7271-7271 doi: 10.3748/wjg.14.7271
|
| 60 |
Lajos Sándor Kiss, Péter László Lakatos. Prediction of the disease course in inflammatory bowel diseases. Orvosi Hetilap 2010; 151(8): 293 doi: 10.1556/oh.2010.28813
|
| 61 |
J.L. Mendoza, M.T. Abreu. Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique 2009; 33: S158 doi: 10.1016/S0399-8320(09)73151-3
|
| 62 |
D. A. Kuznetsova, S. V. Lapin, O. B. Shchukina, I. V. Gubonina, A. A. Kamanin. Predictive value of ASCA and ANCA in inflammatory bowel diseases. The Scientific Notes of the Pavlov University 2024; 31(1): 37 doi: 10.24884/1607-4181-2024-31-1-37-46
|
| 63 |
Morten H. Vatn, Arne K. Sandvik. Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2015; 50(6): 748 doi: 10.3109/00365521.2015.1033000
|
| 64 |
Naim Abu-Freha, Wafi Badarna, Ina Sigal-Batikoff, Muhammad Abu Tailakh, Ohad Etzion, Jaber Elkrinawi, Arik Segal, Alex Mushkalo, Alex Fich. ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0884-x
|